Prevention of ventilator-induced lung edema by inhalation of nanoparticles releasing ruthenium red

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 6, 2014, Pages 1107-1117

  Jurek, Samuel C ^a,b   Hirano Kobayashi, Mariko ^b   Chiang, Homer ^a   Kohane, Daniel S ^a   Matthews, Benjamin D ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acute respiratory distress syndrome; Ex vivo ventilation perfusion; Inhalation; TRPV4; Ventilator induced lung injury

Indexed keywords

NANOPARTICLE; POLYGLACTIN; RUTHENIUM RED; VANILLOID RECEPTOR 4;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD VESSEL PERMEABILITY; BREATHING; CALCIUM SIGNALING; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; MALE; MOUSE; NEBULIZATION; NONHUMAN; VENTILATOR INDUCED LUNG EDEMA; VENTILATOR INDUCED LUNG INJURY;

ADMINISTRATION, INHALATION; ANIMALS; CALCIUM; CALCIUM SIGNALING; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; PERMEABILITY; PULMONARY ALVEOLI; PULMONARY EDEMA; RESPIRATION; RESPIRATION, ARTIFICIAL; RUTHENIUM RED; TRPV CATION CHANNELS; VENTILATOR-INDUCED LUNG INJURY; VENTILATORS, MECHANICAL;

EID: 84901779349     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0163OC     Document Type: Article

References (51)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-1693. (Pubitemid 41464707)
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349. (Pubitemid 30408719)
3. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
4. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351:327-336.
5. Slutsky AS, Imai Y. Ventilator-induced lung injury, cytokines, PEEP, and mortality: implications for practice and for clinical trials. Intensive Care Med 2003;29:1218-1221. (Pubitemid 37041146)
6. Hamanaka K, Jian MY, Townsley MI, King JA, Liedtke W, Weber DS, Eyal FG, Clapp MM, Parker JC. TRPV4 channels augment macrophage activation and ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2010;299:L353-L362.
7. Hamanaka K, Jian MY, Weber DS, Alvarez DF, Townsley MI, Al-Mehdi AB, King JA, Liedtke W, Parker JC. TRPV4 initiates the acute calcium-dependent permeability increase during ventilator-induced lung injury in isolated mouse lungs. Am J Physiol Lung Cell Mol Physiol 2007; 293:L923-L932. (Pubitemid 47572240)
8. Matthews BD, Thodeti CK, Tytell JD, Mammoto A, Overby DR, Ingber DE. Ultra-rapid activation of TRPV4 ion channels by mechanical forces applied to cell surface beta1 integrins. Integr Biol (Camb) 2010;2:435-442.
9. Thodeti CK, Matthews B, Ravi A, Mammoto A, Ghosh K, Bracha AL, Ingber DE. TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ Res 2009;104:1123-1130.
10. Liedtke W, Choe Y, Martí-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000;103:525-535.
11. Güler AD, Lee H, Iida T, Shimizu I, Tominaga M, Caterina M. Heat-evoked activation of the ion channel, TRPV4. J Neurosci 2002;22:6408-6414. (Pubitemid 35386397)
12. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem 2002;277:47044-47051. (Pubitemid 36159212)
13. Alvarez DF, King JA, Weber D, Addison E, Liedtke W, Townsley MI. Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury. Circ Res 2006;99:988-995. (Pubitemid 44657802)
14. Vriens J, Watanabe H, Janssens A, Droogmans G, Voets T, Nilius B. Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc Natl Acad Sci USA 2004;101:396-401. (Pubitemid 38084261)
15. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003;424:434-438. (Pubitemid 36917492)
16. Kunert-Keil C, Bisping F, Krüger J, Brinkmeier H. Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics 2006;7:159.
17. Nilius B, Vriens J, Prenen J, Droogmans G, Voets T. TRPV4 calcium entry channel: a paradigm for gating diversity. Am J Physiol Cell Physiol 2004;286:C195-C205. (Pubitemid 38146342)
18. Voets T, Prenen J, Vriens J, Watanabe H, Janssens A, Wissenbach U, Bödding M, Droogmans G, Nilius B. Molecular determinants of permeation through the cation channel TRPV4. J Biol Chem 2002;277:33704-33710.
19. Beck-Broichsitter M, Gauss J, Gessler T, Seeger W, Kissel T, Schmehl T. Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles. J Aerosol Med Pulm Drug Deliv 2010;23:47-57.
20. Beck-Broichsitter M, Gauss J, Packhaeuser CB, Lahnstein K, Schmehl T, Seeger W, Kissel T, Gessler T. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. Int J Pharm 2009;367:169-178.
21. Vincent F, Duncton MA. TRPV4 agonists and antagonists. Curr Top Med Chem 2011;11:2216-2226.
22. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science 2010;328:1662-1668.
23. Parker JC, Gillespie MN, Taylor AE, Martin SL. Capillary filtration coefficient, vascular resistance, and compliance in isolated mouse lungs. J Appl Physiol (1985) 1999;87:1421-1427.
24. Rippe B, Parker JC, Townsley MI, Mortillaro NA, Taylor AE. Segmental vascular resistances and compliances in dog lung. J Appl Physiol (1985) 1987;62:1206-1215.
25. Brower RG, Sylvester JT, Permutt S. Flow-volume characteristics in the pulmonary circulation. J Appl Physiol (1985) 1990;69:1746-1753.
26. Hernandez LA, Peevy KJ, Moise AA, Parker JC. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits. J Appl Physiol (1985) 1989;66:2364-2368.
27. Fujimoto K, Parker JC, Kayes SG. Activated eosinophils increase vascular permeability and resistance in isolated perfused rat lungs. Am Rev Respir Dis 1990;142:1414-1421.
28. von Bethmann AN, Brasch F, Nüsing R, Vogt K, Volk HD, Müller KM, Wendel A, Uhlig S. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 1998;157:263-272. (Pubitemid 28071291)
29. Parker JC, Townsley MI, Rippe B, Taylor AE, Thigpen J. Increased microvascular permeability in dog lungs due to high peak airway pressures. J Appl Physiol 1984;57:1809-1816. (Pubitemid 15191381)
30. Parker JC, Townsley MI. Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol 2004;286:L231-L246. (Pubitemid 38129502)
31. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20. (Pubitemid 32144788)
32. Rytting E, Nguyen J, Wang X, Kissel T. Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin Drug Deliv 2008;5:629-639. (Pubitemid 351998253)
33. Chellat F, Merhi Y, Moreau A, Yahia L. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 2005;26:7260-7275. (Pubitemid 41133578)
34. Matthews BD, Overby DR, Mannix R, Ingber DE. Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. J Cell Sci 2006;119:508-518.
35. 2+ fluxes in sarcoplasmic-reticulum vesicles. Biochem J 1993;296:49-52.
36. Kannurpatti SS, Joshi PG, Joshi NB. Calcium sequestering ability of mitochondria modulates influx of calcium through glutamate receptor channel. Neurochem Res 2000;25:1527-1536. (Pubitemid 32052013)
37. Deinum J, Wallin M, Jensen PW. The binding of Ruthenium red to tubulin. Biochim Biophys Acta 1985;838:197-205.
38. Yamada A, Sato O, Watanabe M, Walsh MP, Ogawa Y, Imaizumi Y. Inhibition of smooth-muscle myosin-light-chain phosphatase by Ruthenium Red. Biochem J 2000;349:797-804. (Pubitemid 30609411)
39. Sasaki T, Naka M, Nakamura F, Tanaka T. Ruthenium red inhibits the binding of calcium to calmodulin required for enzyme activation. J Biol Chem 1992;267:21518-21523.
40. Yamashiro K, Sasano T, Tojo K, Namekata I, Kurokawa J, Sawada N, Suganami T, Kamei Y, Tanaka H, Tajima N, et al. Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages. Biochem Biophys Res Commun 2010;398:284-289.
41. Takahashi N, Kozai D, Kobayashi R, Ebert M, Mori Y. Roles of TRPM2 in oxidative stress. Cell Calcium 2011;50:279-287.
42. Thorneloe KS, Cheung M, Bao W, Alsaid H, Lenhard S, Jian MY, Costell M, Maniscalco-Hauk K, Krawiec JA, Olzinski A, et al. An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure. Sci Transl Med 2012;4:159ra148.
43. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012;307:2526-2533.
44. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012;38:1573-1582.
45. Michard F. Bedside assessment of extravascular lung water by dilution methods: temptations and pitfalls. Crit Care Med 2007;35:1186-1192. (Pubitemid 46598972)
46. Ware LB, Matthay MA. Clinical practice: acute pulmonary edema. N Engl J Med 2005;353:2788-2796. (Pubitemid 43016818)
47. Curry FE. Mechanics and thermodynamics of transcapillary exchange. In: Renkin EM, Michel CC, editors. The cardiovascular system. Bethesda: American Physiological Society; 1984. pp. 309-374.
48. Parker JC, Townsley MI. Physiological determinants of the pulmonary filtration coefficient. Am J Physiol Lung Cell Mol Physiol 2008;295:L235-L237.
49. Vincent F, Acevedo A, Nguyen MT, Dourado M, DeFalco J, Gustafson A, Spiro P, Emerling DE, Kelly MG, Duncton MA. Identification and characterization of novel TRPV4 modulators. Biochem Biophys Res Commun 2009;389:490-494.
50. Beck-Broichsitter M, Schmehl T, Seeger W, Gessler T. Evaluating the controlled release properties of inhaled nanoparticles using isolated, perfused, and ventilated lung models. J Nanomater 2011;2011:1-16.
51. Rogueda PG, Traini D. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects. Expert Opin Drug Deliv 2007;4:595-606. (Pubitemid 350193398)